PhD: Tel-Aviv University, Tel-Aviv, Israel, 2006.
MD: Tel-Aviv University, Tel-Aviv, Israel, 2007.
Residency: Pediatrics, Sheba Medical Center, Tel -Hashomer, Israel, 2011.
Fellowship: Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2014.
Gastroenterology GI, Autoimmune Liver Disease
Gastroenterology Hepatology and Nutrition
Reduced LHFPL3-AS2 lncRNA expression is linked to altered epithelial polarity and proliferation, and to ileal ulceration in Crohn disease. Scientific Reports. 2023; 13:20513.
Baseline Peripheral Blood Mononuclear Cell Transcriptomics Before Ustekinumab Treatment Is Linked With Crohn's Disease Clinical Response at 1 Year. Clinical and Translational Gastroenterology. 2023; 14:e00635.
Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit. Scientific Reports. 2023; 13:2007.
Integrative –‘Omics and Machine-Learning-Based Image Analyses of Environmental Enteric Dysfunction Reveal an Immunologic and Metabolic Pathogenesis of Intestinal Failure. 2023.
Mucosal transcriptomics highlight lncRNAs implicated in ulcerative colitis, Crohn's disease, and celiac disease. JCI insight. 2023; 8:e170181.
Achieving pan-microbiome biological insights via the dbBact knowledge base. Nucleic Acids Research. 2023; 51:6593-6608.
Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Haematologica: the hematology journal. 2023; 108:1803-1816.
GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis. Journal of Crohn's and Colitis. 2023; 17:960-971.
Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 2023; 21:1338-1347.
Infantile-onset inflammatory bowel disease has variable long-term outcomes. Frontiers in Pediatrics. 2023; 11:1097779.